Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-007-9746-x.pdf
Reference28 articles.
1. Vignot S, Faivere S, Aguirre D, Raymond E (2005) mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol 16:525–537
2. Rowinsky EK (2004) Targeting the molecular target of rapamycin (mTOR). Curr Opin Oncol 16:564–575
3. Noh WC, Paik NS (2003) Translational regulation: a novel target for breast cancer therapy. J Korean Breast Cancer Soc 6:8–14
4. Morgensztern D, McLeod HL (2005) PI3K/Akt/mTOR pathway as a target for cancer therapy. Anti-Cancer Drug 16:797–803
5. Carraway H, Hidalgo M (2004) New target for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists. Breast Cancer Res 6:219–224
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Anti-Cancer Stem Cell Compounds: A Comprehensive Review;Pharmaceutics;2024-08-01
2. CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer;Biology;2024-06-28
3. PIK3CA mutations and PTEN loss: Effects on neoadjuvant trastuzumab in Vietnamese breast cancer patients;Journal of Advanced Pharmacy Education and Research;2024
4. Loss of PTEN Expression, PIK3CA Mutations, and Breast Cancer Survival in the Nurses’ Health Studies;Cancer Epidemiology, Biomarkers & Prevention;2022-08-01
5. Biguanides drugs: Past success stories and promising future for drug discovery;European Journal of Medicinal Chemistry;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3